by German Cancer Research Center Certain anchor proteins inhibit a key metabolic driver that plays an important role in cancer and developmental brain disorders. Scientists from the German Cancer Research Center (DKFZ) and the University of Innsbruck, together with a Europe-wide research network, discovered this molecular mechanism, which could open up new opportunities for personalized therapies for cancer...
by Ryan O’hare, Imperial College London Credit: CC0 Public Domain Medicinal cannabis could offer patients significant relief from intractable epilepsy, but cost and access barriers remain, a review has found. Cannabis-based medicinal products (CBMPs) can offer patients significant relief from intractable epilepsy, according to evidence from a small number of patients. In a review of 10 cases of severe...
by University of Copenhagen Epilepsy is one of the most common neurological diseases. It is caused by a malfunction in brain cells and is usually treated with medicines that control or counteract the seizures. Scientists from the Faculty of Health and Medical Sciences, University of Copenhagen and Rigshospitalet have now identified the exact neurons that are most affected...
by European College of Neuropsychopharmacology Credit: Pixabay/CC0 Public Domain A new comprehensive analysis on the effect of Mozart’s music on epilepsy has confirmed that listening to his piano music can reduce the frequency of epilepsy attacks. The results of this comprehensive meta-analysis (a study of studies), which may overturn current skepticism about the effect, are presented...
by American Physiological Society New research in mice highlights the potential protective effect of microglia—a type of non-neuronal cell in the brain—against overactivation of the central nervous system during acute epileptic seizures. The study is published in the American Journal of Physiology-Cell Physiology. Epilepsy is a brain disorder in which the electrical activity of the...
By Sara Ryding, B.Sc.Reviewed by Emily Henderson, B.Sc. Epilepsy is a common neurological disorder that affects 65 million people around the world. Despite being so common, it is generally not well understood and around one-third of those afflicted cannot control their condition with medication. One of the emerging ways to deal with epilepsy is to...
by Foundation For Research and Technology – Hellas, Foundation for Research and Technology – Hellas The laboratories of Drs. Peyman Golshani at the University of California in Los Angeles, Tristan Shuman at Mount Sinai Hospital in New York, and Panayiota Poirazi at the Institute of Molecular Biology & Biotechnology (IMBB) at the Foundation for Research...
Innovative research uncovers mechanism behind epilepsy in Angelman syndrome SINGAPORE, 15 January 2020 – A key mechanism underlying neuronal dysfunction in Angelman syndrome (AS), a syndromic form of autism spectrum disorder, has – for the first time – been revealed through innovative research led by Duke-NUS Medical School and the National Neuroscience Institute (NNI) under...
by Wiley Results from a study published in the British Journal of Clinical Pharmacology may help explain why cannabidiol—a chemical component of marijuana with no psychoactive properties—reduces the frequency of seizures in patients with a severe form of epilepsy. The effect may be explained by a drug-drug interaction between cannabidiol and the anti-seizure medication clobazam....
by University of Manchester Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers. Hereditary spastic paraplegias (HSP) are a group of genetic disorders that cause weakness and stiffness in the leg muscles. Generally symptoms gradually get worse over time, and severely affected patients are...
